Pharmaceuticals, Biotechnology and Life Sciences
Daix (France), April 26, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development…
Agreement expands Veloxis’ product portfolio and the continued commitment to improving the lives of transplant patients.OSE Immunotherapeutics to receive up…
KEEGO HARBOR, Mich., April 26, 2021 (GLOBE NEWSWIRE) — ZIVO Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the…
This is a joint press release by Sanofi Foreign Participations B.V. (the “Offeror”), Sanofi (“Sanofi”) and Kiadis Pharma N.V. (“Kiadis”)…
Non-dilutive capital will support advancement of ADXS-HOT neoantigen programPRINCETON, N.J., April 26, 2021 (GLOBE NEWSWIRE) — Advaxis, Inc. (NASDAQ: ADXS), a…
LONDON and DUBLIN, April 23, 2021 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH) (GW) and Jazz Pharmaceuticals plc (Nasdaq:…
SUZHOU and SHANGHAI, China, April 23, 2021 (GLOBE NEWSWIRE) — Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical…
MALVERN, Pa., April 23, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing…
Lille, France; Cambridge, MA; April 23, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving…
PD-1 Antagonist Antibody Under Clinical Development for Solid Tumors in Collaboration with GlaxoSmithKline (GSK)First AnaptysBio-Generated Antibody, of 8 Currently Under…